Back to search

Ireland· IE-PA-EU/1/17/1239/003-004

VeraSeal 80 mg/ml/500 IU/ml Solutions for sealant

A local hemostatics product containing human fibrinogen, registered in Ireland by Instituto Grifols S.A.. The same ATC class is registered in 7 of our 19 countries.

ATC B02BC

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedVeraSeal 80 mg/ml/500 IU/ml Solutions…ATCB02BCREGISTER NO.IE-PA-EU/1/17/1239/00…PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Human fibrinogen is registered in 7 of 19 countries.

Countries holding a registration under ATC B02BC (local hemostatics), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 6 of them publish a price we can compare per daily dose

Human fibrinogen · ATC B02BC

7 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Icelandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Human fibrinogen
Manufacturer
Instituto Grifols S.A.
Country
Ireland (IE)
ATC code
B02BC
ATC class
Local hemostatics
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/17/1239/003-004

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Human fibrinogen in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All human fibrinogen products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Fibclot, Fibryga
  • Belgium · Fibclot, Fibryga
  • Bulgaria · Fibryga, Хемокомплетан P
  • Cyprus · Fibryga, Riastap
  • Czechia · Fibryga, Haemocomplettan P
  • Germany · Fibclot, Fibryga
  • Denmark · Fibclot, Fibryga
  • Estonia · Fibryga
  • Spain · Fibclot, Fibryga
  • Finland · Fibclot, Fibryga
  • France · Clottafact, Fibryga
  • United Kingdom (Northern Ireland) · Fibclot, Fibryga
  • Greece · Fibclot, Riastap
  • Croatia · Fibryga
  • Hungary · Fibclot, Fibryga
  • Iceland · Fibryga, Riastap
  • Italy · Fibriclotte, Fibryga
  • Lithuania · Fibryga
  • Luxembourg · Fibclot, Fibryga
  • Latvia · Fibryga
  • Malta · Fibryga, Riastap
  • Netherlands · Fibclot, Fibryga
  • Norway · Fibclot, Fibryga
  • Poland · Fibryga, Riastap
  • Portugal · Fibryga, Haemocomplettan
  • Romania · Fibryga, Haemocomplettan P
  • Sweden · Fibclot, Fibryga
  • Slovenia · Fibrema, Prufibry
  • Slovakia · Fibryga, Riastap

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ad5a95bd-8219-40ad-a4d8-a50d5d6024ea
GET /v1/drugs/ad5a95bd-8219-40ad-a4d8-a50d5d6024ea?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for sealant",
  "routes": [
    "Epilesional use"
  ],
  "source": "hpra",
  "atc_all": [
    "B02BC"
  ],
  "strength": null,
  "pa_number": "EU/1/17/1239/003-004",
  "substances": [
    "Human fibrinogen"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "10/11/2017",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about human fibrinogen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.